Status:
WITHDRAWN
Improving Case Selection for Perioperative S. Aureus Transmission Surveillance to Reduce Surgical Site Infections
Lead Sponsor:
Randy Loftus
Collaborating Sponsors:
RDB Bioinformatics
Conditions:
S. Aureus Transmission
Eligibility:
All Genders
18-120 years
Brief Summary
The first patient in the dyad will receive the bundle, which includes patient decolonization methods, environmental cleaning in the OR, a hand hygiene system located on the IV pole for the anesthesia ...
Detailed Description
Surgical site infections increase patient morbidity and healthcare costs. The Centers for Disease Control and Prevention emphasizes improved basic preventive measures to reduce bacterial transmission ...
Eligibility Criteria
Inclusion
- Patients scheduled to undergo oncologic gynecological and plastic surgery requiring general/regional anesthesia.
- informed, written consent.
Exclusion
- Patients \<18 years of age.
- Patients scheduled to undergo procedures outside of the surgical service lines listed above.
- Patients not requiring general or regional anesthesia.
- Patients who have a documented allergy or have an allergic reaction to to iodine, shellfish, or chlorhexidine.
- Patients who have not provided informed, written consent.
Key Trial Info
Start Date :
March 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04299737
Start Date
March 9 2020
End Date
August 1 2021
Last Update
July 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242